Question 1

What is APRE's dilution risk score?

Accepted Answer

APRE currently has a DilutionScore of 39/100, indicating medium dilution risk. DilutionWatch monitors APRE SEC filings in real-time, scanning EDGAR every 60 seconds for shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals.

Question 2

What SEC filings does DilutionWatch track for APRE?

Accepted Answer

DilutionWatch tracks 25 SEC filing types for APRE including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

Question 3

How does stock dilution affect APRE shareholders?

Accepted Answer

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For APRE, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Question 4

Is DilutionWatch free for APRE tracking?

Accepted Answer

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for APRE. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

APRE — Aprea Therapeutics, Inc. Dilution Risk Tracker

📊 Score Breakdown

🌦️ Dilution Forecast

💹 Market Data

🏛 Institutional Holdings

📉 Short Interest

👤 Insider Buy/Sell Ratio

📁 Recent SEC Activity

📰 Recent News